 Hey guys, this is Ritz from Ritchie B. Live, and we have some breaking news cure-leaf Q through revenue Wow, the Q through your revenue grows 289% to 21.4 million as company projects. Are you ready for this? 400 million in revenue in 2019 Wow, that's right 400 million in revenue in 2019 and let's just take a look at the price of Cura, okay? We will go to trading view and we click on chart and everything was down today in the cannabis sector Let's see what Cura is trading at right now. Let's take a look at it cure-leaf cure-leaf LDVTF in America currently trading at $6.39 it's one of the few companies that actually was in the green today Look at this at $6.39 hit a bottom at around $4.84 Ever since its IPO here you can see let's look at the three month chart Yeah, you can see the lowest they've ever been is $4.85 so that would be the low low right here That would be the low low and it's currently at $6.39 so it's been climbing from the bottom and it's been as high as $8 and 74 cents what do you think about this if you like this smash the like button comment down below this revenue is enormous a projected 400 million in 2019 would make them number one. That's right. It would make them number one unbelievable Cura-leaf reports third quarter 2018 financials and operational results total revenue for Q3 and nine months 2018 increased 289% and 247% respectively total revenue for Q3 2018 increased 46% subsequently compared to Q2 2018 on a pro forma basis consolidated and nonprofit entities Revenue for Q3 and nine months 2018 was 25 million and 55 million respectively successfully raised approximately 400 million in over-subscribed private placements Wow ended Q3 2018 with 29 Cura-leaf retail locations on pace to have over 40 locations by end of 2018 and at least 67 locations by end of 2019 Cura-leaf Holdings Inc. Cura on the CSE a leading vertically Integrated cannabis operator in the United States today reported its unaudited Financials and operating results for the third quarter and nine months ended September 30th 2018 boasting the largest retail dispensary footprint under a single unified brand With now 33 locations across 10 states Cura-leaf has established itself as a leader in the burgeoning US cannabis industry The expansion of our retail footprint was one of several key factors that drove significant year over year quarterly revenue growth of 289% a majority of which was attributable to organic growth Joe Lusardi Chief Executive Officer of Cura-leaf with the closing of our US 400 million private placement and Going public transaction in October. We strengthened both our balance sheet and ability to accelerate our growth objectives in 2019 With a strengthened balance sheet. We are actively seeking Accreditive acquisitions in several major markets across the United States including Maryland Massachusetts Nevada Florida Arizona and Connecticut We are confident that strong organic growth combined with a sound merger and acquisition Strategy will allow Cura-leaf to establish the first national cannabis retail dispensary brand in the United States. Wow Financial highlights for the third quarter ended September 30th 2018 total revenue was 21.4 million as increased of 289% compared to 5.5 million in Q3 2017 that is substantial total revenue increased 47% sequentially compared to 14.6 million in Q2 2018 on a pro forma basis Consolidated nonprofit entities revenue for the third quarter was 25 million gross profit excluding the impact of biological assets was 13.8 million an increase of 360% compared to 3 million in Q3 2017 gross profit margin excluding the impact of biological assets was 64% compared to 55% in Q3 2017 adjusted EBITDA loss was 5.5 million compared to a loss of 0.2 million in Q3 2017 net loss was 33.7 million for the 2018 third quarter including a 25 million one-time non-cash accounting entry as part of the RTO transaction and investment into new store openings and facilities compared to a net income of 0.5 in Q3 2017 so the majority of that 25 million was a one-time fee that they won't be having in the future These are growing pains people Financial highlights for the nine months ended September 30th 2018 total revenue for the nine months ended September 30th 2018 was 45.1 million an increase of 247% compared to 13 million for the same period in 2017 on a pro forma basis Consolidated for nonprofit entities revenue for the first nine months of 2018 was 55 million gross profit Excluding the impact of biological assets assets was 25.9 million an increase of 275% Compared to 6.9 million for the nine months ended September 30th 2018 Gross profit margin excluding the impact of biological assets was 57% for the nine months ended September 30th 2018 Compared to 53% in the same period in the prior year adjusted EBITDA lost total 12.9 million for the nine months ended September 30th 2018 compared to a loss of 3.5 million for the same period of 2017 net loss was 40.8 million for the nine months ended September 30th 2018 Which included a 25 million one-time non-cash? Accounting entry as part of the RTO transaction and investments in new store openings and facilities Compared to a net loss of 3.5 million for the same period of 2017 year-to-year highlights industry firsts first cannabis company to achieve the safe quality food certification under the global food safety initiative first cannabis company in New Jersey to formulate and sell vaporizer cartridges to patient patients first cannabis company in New York within 2017 License class to open a dispensary three dispensaries opened year-to-date First cannabis company to open drive-through dispensary on the East Coast Wow a drive-through dispensary. I love it Acquisition activity in April acquired swell pharmacy a vertically integrated Arizona Operator with four dispensaries in October acquired Midtown roots the only dispensary located in the heart of downtown Phoenix, Arizona Retail footprint expansion as of September 30 2018 the retail footprint of cure-leaf branded dispensaries was 29 locations as of November 26 2018 there are a total of 33 locations including new stores in North Miami Tampa and Tallahassee, Florida and a new store in downtown Phoenix, Arizona Capital markets financing financing activities and growth strategy October 25 2018 cure-leaf raised approximately 400 million in an over-subscribed private placement offering use of proceeds apply for and win new licenses leveraging management's expertise and track track record of successfully doing so through competitive application process in strict regulatory environments enter new markets through Accreditive acquisitions have already committed approximately 83.5 million to fund acquisitions in Maryland Massachusetts Nevada and Arizona with an additional 83 million for minority buyouts in Massachusetts, Florida and Connecticut increase existing production capacity and new dispensary openings Budgeting approximately 80 million to increase cultivation and processing capacity in existing Licensed states to meet expected demand and to open new dispensaries to reach the maximum number of stores permitted under license currently held increase same store sales in existing dispensaries October 29 2018 completed RTO and public listing on the Canadian security exchange under the symbol Cura Financial results for third quarter ended September 30 of 2018 total revenue for third quarter 2018 increased 289% to 21.4 million compared to 4.5 million in the third quarter of 2017 the increase was primarily attributed to growth in the company's retail and wholesale segment revenue for the third quarter of 2018 increased 47% compared to 14.6 million in the second quarter of 2018 retail and wholesale revenue increased 472% to 16.6 million during the quarter compared to 2.9 million in the third quarter of 2017 this year over year growth is Staggering and if they can get a 400 million by next year, this is a grossly undervalued stock This increase was primarily driven by increased sales attributed to new retail dispensaries in Florida New York and Massachusetts and the acquisition of swell in April of 2018 on a pro forma basis including revenue generated by nonprofit entities Gross revenue for the third quarter was 25 million total gross profit Excluding the impact of biological assets for the third quarter 2018 was 13.8 million Representing a gross margin of 64 percent compared to gross profit of 3 million and a gross margin of 55 percent in the third quarter of 2017 as Cura leaf continues to grow its business and achieve scale particularly in limited licensed markets including Florida, New York, Maryland and Massachusetts the company expects its gross profits margin to expand meaningfully in 2019 Adjusted EBITTA loss was 5.5 million for the 2018 third quarter compared to a loss of 0.2 million for the third quarter of 2017 net loss for the third quarter of 2018 was 33.8 million Compared to net income of 0.5 million So a lot of people are gonna look at that number and they're probably gonna say that they spend too much money but this was for growth in the third quarter of 2017 the increase in net loss was primarily driven right here notice this line by a 25 million one-time non-cash accounting entry as part of the RTO the reverse takeover Transaction and investments in new stores openings and facilities and if they grow to 400 million No one's gonna remember that Financial results of the nine months ended September 30th 2018 total revenue for the nine months ended September 30th 2018 increased 247 percent to 45 point one million compared to 13 million in the same period of 2017 increased revenue are primarily attributed to growth of the company's retail and wholesale segment retail and wholesale revenue increased 463 percent to 33.8 million during the nine months ended September 30th 2018 compared to 6 million in the same period of 2017 This is primarily driven by increased sales from the opening of new retail dispensary and production facilities total gross profit excluding the impact of biological assets for the nine months ended September 30th 2018 was 25.9 million Representing a total gross margin of 57% Compared to gross profit of 6.9 million and a gross margin of 53% in the same period of 2017 I just that EBITDA loss was 12.9 million for the nine months ended September 30th 2018 due to forward spending on cultivation and manufacturing capacity This is the first inning people dispensary openings and increased marketing activities net loss for nine months ended September 30th 2018 was 40.8 million compared to a net loss of 3.5 million in the same period of 2017 the increase in net loss was again primarily driven by a one-time non-cash Accounting entry as part of the RTO transaction and investments including new store openings and facilities balance sheet and liquidity as of September 30th 2018 the company had 48 million of cash on October 29th 2018 the company received net prop proceeds of approximately 380 million From the completion of its private placement offered as of today the company has approximately 320 million in cash after paying an aggregate of 65 million for the minority biots in Florida and Connecticut of 25 million and 40 million respectively They're using their money to acquire their growth. I love this as of October 25th 2018 total common shares were 457 million 650 35,788 of which 335 million 465,083 are subordinated voting shares and 122 million 170,705 are Multiple voting shares fully diluted and the company has 508,120,208 outstanding shares Which considering how much are held for voting? I think that they are pretty tightly held outlook for the full year 2018 for the full year 2019 cure-leaf estimates revenue of 400 million enterprise-wide Wow Including revenue generated by nonprofits and free cashflow of 100 million the company anticipates completing two acquisitions in the first fourth quarter of 2018 in Maryland and Massachusetts at the end of 2018 cure-leaf anticipates at least 40 operational stores the guidance for the fiscal 2019 are based on number of assumptions including the successful Execution and implementation of a business strategy that allows the company to increase its footprint to at least 67 retail stores by the end of 2019 that is huge That's gonna be 27 new stores on top of the 40 that they want by the end of this year increase same store sales at existing retail dispensaries expansion of current cultivation and Manufacturing capacity receiving the appropriate regulatory approvals that allow the company to enter at least two additional states continued forward momentum of the regulatory landscape in the United States the absence of a significant shift in economic conditions or material changes in the retail competitive environment Wow Consolidated financial statements and management discussion and analysis the company's unaudited Consolidated interim financial statements and accompanying notes as at and for the three and nine months and it's September 30th 2018 are available under the company's profile on Cedar you can visit it at the company's website at IR dot cure-leaf dot-com and There will be a conference call that it is actually just ended today just happened to go over the financials Let's just read about Curly holdings Curly holdings Inc. Is a parent of Curly ink a leading vertically integrated cannabis Operator in the United States headquartered in Wakefield, Massachusetts Curly ink has a presence in 12 states Curly ink operates 33 dispensaries 12 cultivation sites and 10 process processing sites with a focus on highly populated limited licensed states including Florida, Massachusetts, New Jersey and New York Curly ink Leverages its extensive research and development capabilities to distribute cannabis products in multiple formats with the highest standard for safety effectiveness consistent quality and customer care Curly is committed to being the industry's leading resource in education and advancement through the research and Advocacy Curly inks Florida operations were the first in the cannabis industry to receive the safe quality food Certification under the global food safety initiative setting a new standard of excellence. Just visit their website real quick so If you like this video, please smash the like button Remember if you're over 21 you can go to the website and this is the website and Man, they're boasting some huge numbers a 400 million revenue goal in 2019 is staggering. I love this company I think they are grossly undervalued at these prices and based on their revenue projections This could be a 50 or $100 stock in the future. I'm just putting it out there. It's ridiculous This company has so much potential located in America I see this thing going way up. Okay, so at six dollars I think that we could see at least a hundred percent increase from these levels in 2019 and maybe a lot more because their revenues and their earning potential is Going to dwarf that of canopy growth, which we've seen go over $70 in Canada Anything is possible in this cannabis sector. Okay, and cure leaf went up today and was in the green even though they The entire cannabis sector was red today So I believe that we will see green tomorrow based on this enormous news However, they did show a loss. So the short the shorters the speculators the institutions might want to focus on that But I'm more focused on the revenue growth here. I'm more focused on the expansion I'm more focused on the quality of the company. I love this company. I think they have huge potential What do you think about this news? I think it's staggering news And I think the future looks very bright for cure leaf What do you think if you like it smash the like button? Remember this TV live is strictly for education entertainment purposes Do your due diligence do your research before you invest in anything that we talk about here on rich TV live Okay, I just got to put it out there, but I love this company and I think long term. They're going to be a beast Yes, I know the cannabis sector had a tough day today, but that's okay. We are here for the long haul We have seen it grow for the last four years and we will continue to the stocks will go up and down But in the long run, we will be winners What do you guys think? Holler at your boy rich TV live. You can go and visit us at WWW.richTVlive.com Follow us see all the trending news get all the top stock tools you need Cryptocurrencies contact us. We are working with so many companies and you too can be featured on rich TV live Holler at your boy rich TV live at gmail.com What do you think about cure leaf? LDVTF in America what a weird symbol in America LDVTF and in Canada under the symbol Cura Is your boy rich? Live life well with cure leaf. What do you think? You like it? Do your due diligence do your research cure leaf? I'm gonna go learn a little bit more. I'm gonna dig a little deeper I don't own it yet, but if I buy it, I'll let you guys know. I might buy it tomorrow. I'm not kidding I might just buy this tomorrow. All right, there's all the stock information I'm gonna do some more research. I'm out peace